MRSN vs. SGMO
Compare and contrast key facts about Mersana Therapeutics, Inc. (MRSN) and Sangamo Therapeutics, Inc. (SGMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRSN or SGMO.
Key characteristics
| MRSN | SGMO | |
|---|---|---|
| YTD Return | -4.74% | 277.32% |
| 1Y Return | 43.51% | 484.55% |
| 3Y Return (Ann) | -37.18% | -40.72% |
| 5Y Return (Ann) | -4.21% | -26.31% |
| Sharpe Ratio | 0.45 | 3.01 |
| Sortino Ratio | 1.34 | 3.55 |
| Omega Ratio | 1.16 | 1.40 |
| Calmar Ratio | 0.46 | 4.64 |
| Martin Ratio | 0.86 | 10.74 |
| Ulcer Index | 50.58% | 42.96% |
| Daily Std Dev | 96.89% | 153.36% |
| Max Drawdown | -96.16% | -99.40% |
| Current Drawdown | -91.99% | -95.87% |
Fundamentals
| MRSN | SGMO | |
|---|---|---|
| Market Cap | $269.88M | $564.28M |
| EPS | -$0.85 | -$1.38 |
| PEG Ratio | 0.00 | 0.00 |
| Total Revenue (TTM) | $22.24M | $2.88M |
| Gross Profit (TTM) | $20.97M | -$5.20M |
| EBITDA (TTM) | -$65.33M | -$133.70M |
Correlation
The correlation between MRSN and SGMO is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRSN vs. SGMO - Performance Comparison
In the year-to-date period, MRSN achieves a -4.74% return, which is significantly lower than SGMO's 277.32% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRSN vs. SGMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Mersana Therapeutics, Inc. (MRSN) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRSN vs. SGMO - Dividend Comparison
Neither MRSN nor SGMO has paid dividends to shareholders.
Drawdowns
MRSN vs. SGMO - Drawdown Comparison
The maximum MRSN drawdown since its inception was -96.16%, roughly equal to the maximum SGMO drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for MRSN and SGMO. For additional features, visit the drawdowns tool.
Volatility
MRSN vs. SGMO - Volatility Comparison
The current volatility for Mersana Therapeutics, Inc. (MRSN) is 36.01%, while Sangamo Therapeutics, Inc. (SGMO) has a volatility of 61.52%. This indicates that MRSN experiences smaller price fluctuations and is considered to be less risky than SGMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRSN vs. SGMO - Financials Comparison
This section allows you to compare key financial metrics between Mersana Therapeutics, Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities